The role of laparoscopic modified antireflux monoanastomotic gastric bypass in the treatment of morbid obesity

Authors

DOI:

https://doi.org/10.14739/2310-1210.2022.6.263405

Keywords:

metabolic syndrome, morbid obesity, bariatric surgery, biliary reflux, quality of life, gastric bypass, type 2 diabetes

Abstract

Aim. Improving the results of surgical treatment for patients with morbid obesity by evaluating the effectiveness and comparing the results of bariatric operations, namely laparoscopic modified monoanastomotic gastric bypass (LMMGB) and laparoscopic standard Roux-en-Y.
Materials and methods. The work analyzed the results of treatment of 41 patients with morbid obesity. All patients were divided into two groups. LMMGB surgery was performed for 30 patients (the main group). The control group consisted of 11 patients after the standard technique of laparoscopic standard Roux-en-Y. Inclusion criteria were: persons of both sexes aged 18–60 years with morbid obesity and body mass index of 40 kg/m2 or more, as well as 35 kg/m2 or more in the presence of comorbid diseases (type 2 diabetes, hypertension, dyslipidemia, sleep apnea syndrome). Body weight of the patients ranged from 83 kg to 173 kg. The average body mass index was 42.5 kg/m2 in the main group before the operation. Violation of carbohydrate metabolism, which is included in the criteria of metabolic syndrome, was detected in 28 (93.33 %) of 30 studied patients of the main group and in 10 (90.90 %) of 11 studied patients of the control group. Comorbid pathology was found in 76.67 % of the main group and 72.72 % of the control group.
Statistical processing was carried out via the Statistica 13.0 software package using parametric and non-parametric statistical methods.
Results. There were no deaths, anastomosis failures, conversions, and intraoperative complications. The duration of LMMGB operation ranged from 120 to 290 minutes. The postoperative period was 5 days in the main group and 7 days in the control group, that is, a statistically significant reduction in the postoperative period duration was observed. In both groups, a decrease in body weight ranged from 12 kg to 81 kg within 6 months. In the main group, the median weight loss was 26.0 kg after 6 months and 38.5 kg after 12 months. BMI was 31.25 kg/m2 after 6 months, 26.88 kg/m2 after 12 months. In the control group, this indicator was 28.0 kg after 6 months and 42.0 kg after 12 months. Median BMI after 6 months – 31.64 kg/m2, after 12 months – 26.03 kg/m2, respectively. After the operation, there was a tendency towards an increase in all indicators of quality of life, both in the group of patients who underwent gastric bypass according to the classic Roux technique and in the group of patients after LMMGB. Clinical manifestations of the enterogastric biliary reflex were detected in both groups, in addition, clinical manifestations of the corresponding symptoms were noted by patients of both groups. No statistically significant difference was found in these parameters.
Conclusions. Monoanastomotic gastric bypass in the modification of the clinic has the same positive properties as the standard Roux-en-Y technique, allowing to avoid the risks associated with possible pathological reflux of bile into the esophagus. Patients who have undergone a mini-gastric bypass surgery need a thorough examination with fibrogastroscopy in combination with pH-impedance measurement at least once a year in order to determine biliary reflux and morphological changes both in the lumen of the esophagus and in the stump of the stomach. The quality of life level does not significantly differ after surgery between patients of the control group and the main group based on the results of the GERG-Questionnaire indicating the effectiveness of the laparoscopic monoanastomotic gastric bypass technique modified in the clinic.

Author Biographies

A. V. Klymenko, Zaporizhzhia State Medical University, Ukraine

MD, PhD, DSc, Professor of the Department of Faculty Surgery

M. V. Nikolaiev, Zaporizhzhia State Medical University, Ukraine

MD, Postgraduate Student of the Department of Faculty Surgery

References

Rangel-Huerta, O. D., Pastor-Villaescusa, B., & Gil, A. (2019). Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies. Metabolomics, 15(6), 93. https://doi.org/10.1007/s11306-019-1553-y

NCD Risk Factor Collaboration (NCD-RisC) (2017). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet, 390(10113), 2627-2642. https://doi.org/10.1016/S0140-6736(17)32129-3

Flegal, K. M., Kruszon-Moran, D., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2016). Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA, 315(21), 2284-2291. https://doi.org/10.1001/jama.2016.6458

Bray, G. A., Heisel, W. E., Afshin, A., Jensen, M. D., Dietz, W. H., Long, M., Kushner, R. F., Daniels, S. R., Wadden, T. A., Tsai, A. G., Hu, F. B., Jakicic, J. M., Ryan, D. H., Wolfe, B. M., & Inge, T. H. (2018). The Science of Obesity Management: An Endocrine Society Scientific Statement. Endocrine reviews, 39(2), 79-132. https://doi.org/10.1210/er.2017-00253

Bereznitsky, Ya. S., Duka, R. W., Kolesnik, T. V., Kolesnik, E. L., Nadyuk, A. V., & Kosova, G. A. (2017). Pryntsypy obstezhennia khvorykh na morbidne ozhyrinnia i metabolichnyi syndrom, yaki ye kandydatamy dlia vykonannia bariatrychnoho operatyvnoho vtruchannia [Principles of the examination of patients with morbid obesity and metabolic syndrome, which are candidates for the use of bariatric operative exposure]. Sciences of Europe, (21), 5-11. [in Ukrainian].

Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., Bengtsson, C., Dahlgren, S., Gummesson, A., Jacobson, P., Karlsson, J., Lindroos, A. K., Lönroth, H., Näslund, I., Olbers, T., Stenlöf, K., … Swedish Obese Subjects Study (2007). Effects of bariatric surgery on mortality in Swedish obese subjects. The New England journal of medicine, 357(8), 741-752. https://doi.org/10.1056/NEJMoa066254

Rutledge, R. (2001). The mini-gastric bypass: experience with the first 1,274 cases. Obesity surgery, 11(3), 276-280. https://doi.org/10.1381/096089201321336584

Ramanan, B., Gupta, P. K., Gupta, H., Fang, X., & Forse, R. A. (2012). Development and validation of a bariatric surgery mortality risk calculator. Journal of the American College of Surgeons, 214(6), 892-900. https://doi.org/10.1016/j.jamcollsurg.2012.02.011

Lavryk, A. S., & Lavryk, O. A. (2018). Khirurhiia ozhyrinnia ta metabolichnykh rozladiv [Surgery of obesity and metabolic disorders: training. manual]. Quart. [in Ukrainian].

Rutledge, R., & Walsh, T. R. (2005). Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obesity surgery, 15(9), 1304-1308. https://doi.org/10.1381/096089205774512663

Ioffe, O. Yu., Tsyura, Yu. P., Dibrova, Yu. A., Kryvopustov, M. S., Stetsenko, O. P., & Tarasyuk, T. V. (2016) Vdoskonalennia sposobiv formuvannia anastomoziv pry laparoskopichnomu shlunkovomu shuntuvanni [Ways in improving anastomosis during laparoscopic gastric bypass surgery]. Aktualni problemy suchasnoi medytsyny, 16(2), 100-104. [in Ukrainian].

Rutledge, R., Deitel, M., Carbajo, M. A., Luque-de-Leon, E., Chiappetta, S., Inam, A., Rheinwalt, K., Prasad, A., Hargroder, D. E., Samoylov, V., Ozmen, M. M., Parmar, C., Albuquerque, A., Jammu, G., Ustun, M., Sakran, N., Aktimur, R., Khan, A., Hamza, Y., Rotundo, A., … Abbas, I. (2020). Commentary: Cancer after the OAGB-MGB. Obesity surgery, 30(2), 755-758. https://doi.org/10.1007/s11695-019-04313-5

Klymenko, A. V., Klymenko, V. N., Bilai, A. I., & Nikolaiev, M. V. (2020). Modifitsirovannoe antireflyuksnoe monoanastomoznoe laparoskopicheskoe shuntirovanie zheludka v khirurgii morbidnogo ozhireniya [Modified antireflux monoanastomotic laparoscopic gastric bypass in morbid obesity surgery]. Zaporozhye medical journal, 22(5), 676-681. [in Russian]. https://doi.org/10.14739/2310-1210.2020.5.214741

Keleidari, B., Dehkordi, M. M., Shahraki, M. S., Ahmadi, Z. S., Heidari, M., Hajian, A., & Nasaj, H. T. (2021). Bile reflux after one anastomosis gastric bypass surgery: A review study. Annals of medicine and surgery (2012), 64, 102248. https://doi.org/10.1016/j.amsu.2021.102248

Karlsson, J., Taft, C., Rydén, A., Sjöström, L., & Sullivan, M. (2007). Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. International journal of obesity (2005), 31(8), 1248-1261. https://doi.org/10.1038/sj.ijo.0803573

Canetti, L., Elizur, Y., Karni, Y., & Berry, E. M. (2013). Health-related quality of life changes and weight reduction after bariatric surgery vs. a weight-loss program. The Israel journal of psychiatry and related sciences, 50(3), 194-200.

Tompkins, J., Bosch, P. R., Chenowith, R., Tiede, J. L., & Swain, J. M. (2008). Changes in functional walking distance and health-related quality of life after gastric bypass surgery. Physical therapy, 88(8), 928-935. https://doi.org/10.2522/ptj.20070296

Cava, E., Yeat, N. C., & Mittendorfer, B. (2017). Preserving Healthy Muscle during Weight Loss. Advances in nutrition, 8(3), 511-519. https://doi.org/10.3945/an.116.014506

Schneider, J., Peterli, R., Gass, M., Slawik, M., Peters, T., & Wölnerhanssen, B. K. (2016). Laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass lead to equal changes in body composition and energy metabolism 17 months postoperatively: a prospective randomized trial. Surgery for obesity and related diseases, 12(3), 563-570. https://doi.org/10.1016/j.soard.2015.07.002

Lorico, S., & Colton, B. (2020). Medication management and pharmacokinetic changes after bariatric surgery. Canadian family physician Medecin de famille canadien, 66(6), 409-416.

Eaton, C. B., Hartman, S. J., Perzanowski, E., Pan, G., Roberts, M. B., Risica, P. M., Gans, K. M., Jakicic, J. M., & Marcus, B. H. (2016). A Randomized Clinical Trial of a Tailored Lifestyle Intervention for Obese, Sedentary, Primary Care Patients. Annals of family medicine, 14(4), 311-319. https://doi.org/10.1370/afm.1952

Published

2022-12-20

How to Cite

1.
Klymenko AV, Nikolaiev MV. The role of laparoscopic modified antireflux monoanastomotic gastric bypass in the treatment of morbid obesity. Zaporozhye Medical Journal [Internet]. 2022Dec.20 [cited 2024Nov.25];24(6):721-6. Available from: http://zmj.zsmu.edu.ua/article/view/263405

Issue

Section

Original research